Internal Medicine, Endocrinology, Diabetes, & Metabolism · Albuquerque, NM
NPI
1124118963
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5501 Jefferson St NE, Suite #700
Albuquerque, NM, 87109
Phone (505) 872-1002
Groups this clinician bills Medicare through
Medicare paid, 2024
$226K
16,500 services
Medicare patients, 2024
381
Average age 72
Drug cost, 2024
$3.3M
7,563 prescriptions
Company payments, 2025
$811
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert T Ferraro was code J3111 (injection, romosozumab-aqqg, 1 mg), 13,335 times for 11 patients. In total Robert T Ferraro billed 16,500 services in 22 codes, and Medicare paid $226K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 13,335 | 11 | $8.65 | $115K |
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 18 | $19.28 | $27K |
| 99214 Office E&M - Established | Office | 454 | 244 | $86.63 | $39K |
| 95251 Test - Miscellaneous | Office | 382 | 154 | $24.25 | $9,264 |
| 99213 Office E&M - Established | Office | 261 | 192 | $58.65 | $15K |
| 36415 Venipuncture Blood Collection | Office | 131 | 116 | $8.54 | $1,119 |
| 96372 Injection Administration | Office | 113 | 31 | $10.83 | $1,224 |
| 99204 Office E&M - New | Office | 62 | 62 | $114.84 | $7,120 |
| 99211 Office E&M - Established | Office | 30 | 11 | $17.67 | $530 |
| 99203 Office E&M - New | Office | 25 | 25 | $67.57 | $1,689 |
| 99441 Telephone Services | Office | 24 | 22 | $26.73 | $642 |
| 99442 Telephone Services | Office | 17 | 15 | $53.71 | $913 |
| 99205 Office E&M - New | Office | 14 | 14 | $143.76 | $2,013 |
| 99212 Office E&M - Established | Office | 14 | 14 | $40.97 | $574 |
| 10005 Other Organ Systems | Office | 12 | 11 | $90.92 | $1,091 |
By year: 2022 $78K for 1,696 services; 2023 $73K for 1,663 services; 2024 $226K for 16,500 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 131 | 116 | $8.54 | $1,119 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert T Ferraro prescribed most often to Medicare patients was Levothyroxine Sodium, with 426 prescriptions and refills. In total Robert T Ferraro wrote 7,563 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 426 | 827 | 96 | $3,471 |
| Tresiba Flextouch U-200 Insulin Degludec | 406 | 609 | 75 | $515K |
| Ozempic Semaglutide | 354 | 477 | 61 | $444K |
| Jardiance Empagliflozin | 287 | 431 | 55 | $240K |
| Rosuvastatin Calcium Generic | 266 | 597 | 65 | $3,359 |
| Tresiba Flextouch U-100 Insulin Degludec | 207 | 309 | 54 | $126K |
| Glimepiride Generic | 195 | 324 | 43 | $984 |
| Metoprolol Succinate Generic | 179 | 277 | 28 | $1,988 |
| Metformin Hcl Generic | 176 | 412 | 44 | $1,320 |
| Atorvastatin Calcium Generic | 161 | 387 | 44 | $1,660 |
| Mounjaro Tirzepatide | 159 | 204 | 31 | $211K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 142 | 289 | 57 | $12K |
| Humalog Kwikpen U-100 Insulin Lispro | 140 | 199 | 33 | $32K |
| Metformin Hcl Er Metformin Hcl | 140 | 245 | 31 | $1,152 |
| Novolog Flexpen Insulin Aspart | 135 | 233 | 41 | $40K |
Brand drugs: 3,482 claims; generic drugs: 3,586 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert T Ferraro $811 ($811 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbott Laboratories with $199.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 5 | $199 |
| Novo Nordisk Inc NVO | 16 | $148 |
| Medtronic, Inc. MDT | 3 | $145 |
| Insulet Corporation PODD | 6 | $140 |
| Amgen Inc. AMGN | 4 | $84.81 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $50.86 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $14.7 |
| Tactile Systems Technology Inc TCMD | 1 | $14.49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.